<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 10 Aug 2026 08:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)</title>
   <link>http://www.streetinsider.com/Press+Releases/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Approval opens market access across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;UAE&lt;/location&gt; through commercial partner UniTech Solutions, bringing rapid, non-invasive coronary artery disease rule-out to point of care&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ok.oklcty&quot; idsrc=&quot;xmltag.org&quot; &gt;OKLAHOMA CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 10, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Stockholm:ACARIX&quot; idsrc=&quot;xmltag.org&quot; &gt;Acarix AB&lt;/span&gt; (publ) today announced that the CADScor&lt;sup&gt;®&lt;/sup&gt; System has received regulatory approval from the Emirates Drug Establishment (EDE) and the &lt;span&gt;Ministry of Health and Prevention&lt;/span&gt; (MOHAP), clearing the way for commercial availability of the technology across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;United Arab Emirates&lt;/location&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
        </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</guid>
   <pubDate>Mon, 10 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22933846</category>
   	  </item>
  <item>
   <title>Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)</title>
   <link>http://www.streetinsider.com/Press+Releases/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Approval opens market access across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;UAE&lt;/location&gt; through commercial partner UniTech Solutions, bringing rapid, non-invasive coronary artery disease rule-out to point of care&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ok.oklcty&quot; idsrc=&quot;xmltag.org&quot; &gt;OKLAHOMA CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 10, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Stockholm:ACARIX&quot; idsrc=&quot;xmltag.org&quot; &gt;Acarix AB&lt;/span&gt; (publ) today announced that the CADScor&lt;sup&gt;®&lt;/sup&gt; System has received regulatory approval from the Emirates Drug Establishment (EDE) and the &lt;span&gt;Ministry of Health and Prevention&lt;/span&gt; (MOHAP), clearing the way for commercial availability of the technology across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;United Arab Emirates&lt;/location&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
        </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</guid>
   <pubDate>Mon, 10 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22933846</category>
   	  </item>
  <item>
   <title>Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)</title>
   <link>http://www.streetinsider.com/Press+Releases/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Approval opens market access across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;UAE&lt;/location&gt; through commercial partner UniTech Solutions, bringing rapid, non-invasive coronary artery disease rule-out to point of care&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ok.oklcty&quot; idsrc=&quot;xmltag.org&quot; &gt;OKLAHOMA CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 10, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Stockholm:ACARIX&quot; idsrc=&quot;xmltag.org&quot; &gt;Acarix AB&lt;/span&gt; (publ) today announced that the CADScor&lt;sup&gt;®&lt;/sup&gt; System has received regulatory approval from the Emirates Drug Establishment (EDE) and the &lt;span&gt;Ministry of Health and Prevention&lt;/span&gt; (MOHAP), clearing the way for commercial availability of the technology across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;United Arab Emirates&lt;/location&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
        </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</guid>
   <pubDate>Mon, 10 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22933846</category>
   	  </item>
  <item>
   <title>Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)</title>
   <link>http://www.streetinsider.com/Press+Releases/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Approval opens market access across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;UAE&lt;/location&gt; through commercial partner UniTech Solutions, bringing rapid, non-invasive coronary artery disease rule-out to point of care&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ok.oklcty&quot; idsrc=&quot;xmltag.org&quot; &gt;OKLAHOMA CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 10, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Stockholm:ACARIX&quot; idsrc=&quot;xmltag.org&quot; &gt;Acarix AB&lt;/span&gt; (publ) today announced that the CADScor&lt;sup&gt;®&lt;/sup&gt; System has received regulatory approval from the Emirates Drug Establishment (EDE) and the &lt;span&gt;Ministry of Health and Prevention&lt;/span&gt; (MOHAP), clearing the way for commercial availability of the technology across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;United Arab Emirates&lt;/location&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
        </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</guid>
   <pubDate>Mon, 10 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22933846</category>
   	  </item>
  <item>
   <title>Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)</title>
   <link>http://www.streetinsider.com/PRNewswire/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Approval opens market access across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;UAE&lt;/location&gt; through commercial partner UniTech Solutions, bringing rapid, non-invasive coronary artery disease rule-out to point of care&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ok.oklcty&quot; idsrc=&quot;xmltag.org&quot; &gt;OKLAHOMA CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 10, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Stockholm:ACARIX&quot; idsrc=&quot;xmltag.org&quot; &gt;Acarix AB&lt;/span&gt; (publ) today announced that the CADScor&lt;sup&gt;®&lt;/sup&gt; System has received regulatory approval from the Emirates Drug Establishment (EDE) and the &lt;span&gt;Ministry of Health and Prevention&lt;/span&gt; (MOHAP), clearing the way for commercial availability of the technology across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;United Arab Emirates&lt;/location&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
        </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</guid>
   <pubDate>Mon, 10 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22933846</category>
   	  </item>
  <item>
   <title>Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)</title>
   <link>http://www.streetinsider.com/PRNewswire/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Approval opens market access across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;UAE&lt;/location&gt; through commercial partner UniTech Solutions, bringing rapid, non-invasive coronary artery disease rule-out to point of care&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ok.oklcty&quot; idsrc=&quot;xmltag.org&quot; &gt;OKLAHOMA CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 10, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Stockholm:ACARIX&quot; idsrc=&quot;xmltag.org&quot; &gt;Acarix AB&lt;/span&gt; (publ) today announced that the CADScor&lt;sup&gt;®&lt;/sup&gt; System has received regulatory approval from the Emirates Drug Establishment (EDE) and the &lt;span&gt;Ministry of Health and Prevention&lt;/span&gt; (MOHAP), clearing the way for commercial availability of the technology across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;United Arab Emirates&lt;/location&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
        </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</guid>
   <pubDate>Mon, 10 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22933846</category>
   	  </item>
  <item>
   <title>Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)</title>
   <link>http://www.streetinsider.com/PRNewswire/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Approval opens market access across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;UAE&lt;/location&gt; through commercial partner UniTech Solutions, bringing rapid, non-invasive coronary artery disease rule-out to point of care&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ok.oklcty&quot; idsrc=&quot;xmltag.org&quot; &gt;OKLAHOMA CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 10, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Stockholm:ACARIX&quot; idsrc=&quot;xmltag.org&quot; &gt;Acarix AB&lt;/span&gt; (publ) today announced that the CADScor&lt;sup&gt;®&lt;/sup&gt; System has received regulatory approval from the Emirates Drug Establishment (EDE) and the &lt;span&gt;Ministry of Health and Prevention&lt;/span&gt; (MOHAP), clearing the way for commercial availability of the technology across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;United Arab Emirates&lt;/location&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
        </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</guid>
   <pubDate>Mon, 10 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22933846</category>
   	  </item>
  <item>
   <title>Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)</title>
   <link>http://www.streetinsider.com/PRNewswire/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Approval opens market access across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;UAE&lt;/location&gt; through commercial partner UniTech Solutions, bringing rapid, non-invasive coronary artery disease rule-out to point of care&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ok.oklcty&quot; idsrc=&quot;xmltag.org&quot; &gt;OKLAHOMA CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 10, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Stockholm:ACARIX&quot; idsrc=&quot;xmltag.org&quot; &gt;Acarix AB&lt;/span&gt; (publ) today announced that the CADScor&lt;sup&gt;®&lt;/sup&gt; System has received regulatory approval from the Emirates Drug Establishment (EDE) and the &lt;span&gt;Ministry of Health and Prevention&lt;/span&gt; (MOHAP), clearing the way for commercial availability of the technology across the &lt;location value=&quot;LC/ae&quot; idsrc=&quot;xmltag.org&quot; &gt;United Arab Emirates&lt;/location&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
        </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Acarix+Receives+Regulatory+Approval+for+the+CADScor%C2%AE+System+in+the+UAE+%28United+Arab+Emirates%29/26894664.html</guid>
   <pubDate>Mon, 10 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACARIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22933846</category>
   	  </item>
  <item>
   <title>Kepler Cheuvreux Upgrades Acciona SA (ANA:SM) (ACIXF) to Hold</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</link>
   <description>&lt;p&gt;Kepler Cheuvreux analyst Jose Porta upgraded Acciona SA (ANA:SM) (OTC: ACIXF) from Reduce to Hold with a price target of EUR225.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade Acciona from Reduce to Hold following a c. 25% correction from its peak of EUR285/share. H1-26 results came in a bit ahead of our estimates, and management reiterated FY-26 guidance. We leave our estimates and EUR225 TP unchanged. The latest leg of the correction coincided with the sale of c. 3.0% of the capital by Tussen de Grachten (the Entrecanales Franco family vehicle) at EUR217.9/share. According to the company, the transaction was undertaken to facilitate</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</guid>
   <pubDate>Fri, 07 Aug 2026 03:20:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Kepler Cheuvreux Upgrades Acciona SA (ANA:SM) (ACIXF) to Hold</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</link>
   <description>&lt;p&gt;Kepler Cheuvreux analyst Jose Porta upgraded Acciona SA (ANA:SM) (OTC: ACIXF) from Reduce to Hold with a price target of EUR225.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade Acciona from Reduce to Hold following a c. 25% correction from its peak of EUR285/share. H1-26 results came in a bit ahead of our estimates, and management reiterated FY-26 guidance. We leave our estimates and EUR225 TP unchanged. The latest leg of the correction coincided with the sale of c. 3.0% of the capital by Tussen de Grachten (the Entrecanales Franco family vehicle) at EUR217.9/share. According to the company, the transaction was undertaken to facilitate</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</guid>
   <pubDate>Fri, 07 Aug 2026 03:20:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Kepler Cheuvreux Upgrades Acciona SA (ANA:SM) (ACIXF) to Hold</title>
   <link>http://www.streetinsider.com/Upgrades/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</link>
   <description>&lt;p&gt;Kepler Cheuvreux analyst Jose Porta upgraded Acciona SA (ANA:SM) (OTC: ACIXF) from Reduce to Hold with a price target of EUR225.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade Acciona from Reduce to Hold following a c. 25% correction from its peak of EUR285/share. H1-26 results came in a bit ahead of our estimates, and management reiterated FY-26 guidance. We leave our estimates and EUR225 TP unchanged. The latest leg of the correction coincided with the sale of c. 3.0% of the capital by Tussen de Grachten (the Entrecanales Franco family vehicle) at EUR217.9/share. According to the company, the transaction was undertaken to facilitate</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</guid>
   <pubDate>Fri, 07 Aug 2026 03:20:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Kepler Cheuvreux Upgrades Acciona SA (ANA:SM) (ACIXF) to Hold</title>
   <link>http://www.streetinsider.com/Upgrades/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</link>
   <description>&lt;p&gt;Kepler Cheuvreux analyst Jose Porta upgraded Acciona SA (ANA:SM) (OTC: ACIXF) from Reduce to Hold with a price target of EUR225.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade Acciona from Reduce to Hold following a c. 25% correction from its peak of EUR285/share. H1-26 results came in a bit ahead of our estimates, and management reiterated FY-26 guidance. We leave our estimates and EUR225 TP unchanged. The latest leg of the correction coincided with the sale of c. 3.0% of the capital by Tussen de Grachten (the Entrecanales Franco family vehicle) at EUR217.9/share. According to the company, the transaction was undertaken to facilitate</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</guid>
   <pubDate>Fri, 07 Aug 2026 03:20:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Kepler Cheuvreux Upgrades Acciona SA (ANA:SM) (ACIXF) to Hold</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</link>
   <description>&lt;p&gt;Kepler Cheuvreux analyst Jose Porta upgraded Acciona SA (ANA:SM) (OTC: ACIXF) from Reduce to Hold with a price target of EUR225.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade Acciona from Reduce to Hold following a c. 25% correction from its peak of EUR285/share. H1-26 results came in a bit ahead of our estimates, and management reiterated FY-26 guidance. We leave our estimates and EUR225 TP unchanged. The latest leg of the correction coincided with the sale of c. 3.0% of the capital by Tussen de Grachten (the Entrecanales Franco family vehicle) at EUR217.9/share. According to the company, the transaction was undertaken to facilitate</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</guid>
   <pubDate>Fri, 07 Aug 2026 03:20:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Kepler Cheuvreux Upgrades Acciona SA (ANA:SM) (ACIXF) to Hold</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</link>
   <description>&lt;p&gt;Kepler Cheuvreux analyst Jose Porta upgraded Acciona SA (ANA:SM) (OTC: ACIXF) from Reduce to Hold with a price target of EUR225.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade Acciona from Reduce to Hold following a c. 25% correction from its peak of EUR285/share. H1-26 results came in a bit ahead of our estimates, and management reiterated FY-26 guidance. We leave our estimates and EUR225 TP unchanged. The latest leg of the correction coincided with the sale of c. 3.0% of the capital by Tussen de Grachten (the Entrecanales Franco family vehicle) at EUR217.9/share. According to the company, the transaction was undertaken to facilitate</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Kepler+Cheuvreux+Upgrades+Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+to+Hold/26886378.html</guid>
   <pubDate>Fri, 07 Aug 2026 03:20:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR225 at Kepler Cheuvreux</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR225+at+Kepler+Cheuvreux/26643340.html</link>
   <description>Kepler Cheuvreux analyst Jose Porta raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR225.00  (from EUR213.00) while maintaining a Reduce rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR225+at+Kepler+Cheuvreux/26643340.html</guid>
   <pubDate>Mon, 15 Jun 2026 05:07:25 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR225 at Kepler Cheuvreux</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR225+at+Kepler+Cheuvreux/26643340.html</link>
   <description>Kepler Cheuvreux analyst Jose Porta raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR225.00  (from EUR213.00) while maintaining a Reduce rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR225+at+Kepler+Cheuvreux/26643340.html</guid>
   <pubDate>Mon, 15 Jun 2026 05:07:25 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR225 at Kepler Cheuvreux</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR225+at+Kepler+Cheuvreux/26643340.html</link>
   <description>Kepler Cheuvreux analyst Jose Porta raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR225.00  (from EUR213.00) while maintaining a Reduce rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR225+at+Kepler+Cheuvreux/26643340.html</guid>
   <pubDate>Mon, 15 Jun 2026 05:07:25 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR225 at Kepler Cheuvreux</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR225+at+Kepler+Cheuvreux/26643340.html</link>
   <description>Kepler Cheuvreux analyst Jose Porta raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR225.00  (from EUR213.00) while maintaining a Reduce rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR225+at+Kepler+Cheuvreux/26643340.html</guid>
   <pubDate>Mon, 15 Jun 2026 05:07:25 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR184 at Citi</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR184+at+Citi/26607662.html</link>
   <description>Citi analyst Jenny Ping raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR184.00  (from EUR135.00) while maintaining a Sell rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR184+at+Citi/26607662.html</guid>
   <pubDate>Fri, 05 Jun 2026 04:23:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR184 at Citi</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR184+at+Citi/26607662.html</link>
   <description>Citi analyst Jenny Ping raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR184.00  (from EUR135.00) while maintaining a Sell rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR184+at+Citi/26607662.html</guid>
   <pubDate>Fri, 05 Jun 2026 04:23:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR184 at Citi</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR184+at+Citi/26607662.html</link>
   <description>Citi analyst Jenny Ping raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR184.00  (from EUR135.00) while maintaining a Sell rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR184+at+Citi/26607662.html</guid>
   <pubDate>Fri, 05 Jun 2026 04:23:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR184 at Citi</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR184+at+Citi/26607662.html</link>
   <description>Citi analyst Jenny Ping raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR184.00  (from EUR135.00) while maintaining a Sell rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR184+at+Citi/26607662.html</guid>
   <pubDate>Fri, 05 Jun 2026 04:23:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR170 at RBC Capital</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR170+at+RBC+Capital/26511336.html</link>
   <description>RBC Capital analyst Fernando Garcia raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR170.00  (from EUR145.00) while maintaining a Underperform rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR170+at+RBC+Capital/26511336.html</guid>
   <pubDate>Mon, 18 May 2026 09:22:11 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR170 at RBC Capital</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR170+at+RBC+Capital/26511336.html</link>
   <description>RBC Capital analyst Fernando Garcia raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR170.00  (from EUR145.00) while maintaining a Underperform rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR170+at+RBC+Capital/26511336.html</guid>
   <pubDate>Mon, 18 May 2026 09:22:11 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
  <item>
   <title>Acciona SA (ANA:SM) (ACIXF) PT Raised to EUR170 at RBC Capital</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR170+at+RBC+Capital/26511336.html</link>
   <description>RBC Capital analyst Fernando Garcia raised the price target on Acciona SA (ANA:SM) (OTC: ACIXF) to EUR170.00  (from EUR145.00) while maintaining a Underperform rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Acciona+SA+%28ANA%3ASM%29+%28ACIXF%29+PT+Raised+to+EUR170+at+RBC+Capital/26511336.html</guid>
   <pubDate>Mon, 18 May 2026 09:22:11 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ACIXF</category>
   	  </item>
 </channel>
</rss>
